HU0004132A3 - Rapidly soluble drug composition - Google Patents

Rapidly soluble drug composition

Info

Publication number
HU0004132A3
HU0004132A3 HU0004132A HU0004132A HU0004132A3 HU 0004132 A3 HU0004132 A3 HU 0004132A3 HU 0004132 A HU0004132 A HU 0004132A HU 0004132 A HU0004132 A HU 0004132A HU 0004132 A3 HU0004132 A3 HU 0004132A3
Authority
HU
Hungary
Prior art keywords
drug composition
soluble drug
rapidly soluble
rapidly
composition
Prior art date
Application number
HU0004132A
Other versions
HU0004132A2 (en
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP30663597 priority Critical
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Priority to PCT/JP1998/004658 priority patent/WO1999020277A1/en
Publication of HU0004132A2 publication Critical patent/HU0004132A2/en
Publication of HU0004132A3 publication Critical patent/HU0004132A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/499Spiro-condensed pyrazines or piperazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/951Powders, granules or particles of specified mesh or particle size
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/96Significant, tablet formulation, e.g. designated excipient, disintegrant, glydent or lubricant
HU0004132A 1997-10-20 1998-10-15 Rapidly soluble drug composition HU0004132A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP30663597 1997-10-20
PCT/JP1998/004658 WO1999020277A1 (en) 1997-10-20 1998-10-15 Rapidly soluble drug composition

Publications (2)

Publication Number Publication Date
HU0004132A2 HU0004132A2 (en) 2001-08-28
HU0004132A3 true HU0004132A3 (en) 2006-06-28

Family

ID=17959478

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004132A HU0004132A3 (en) 1997-10-20 1998-10-15 Rapidly soluble drug composition

Country Status (22)

Country Link
US (2) US7141249B2 (en)
EP (1) EP1033132B1 (en)
KR (1) KR100571614B1 (en)
CN (1) CN1156277C (en)
AT (1) AT296101T (en)
AU (1) AU740299B2 (en)
BR (1) BR9814090A (en)
CA (1) CA2306883C (en)
CZ (1) CZ299018B6 (en)
DE (1) DE69830333T2 (en)
ES (1) ES2242298T3 (en)
HK (1) HK1030359A1 (en)
HU (1) HU0004132A3 (en)
ID (1) ID23915A (en)
NO (1) NO319049B1 (en)
NZ (1) NZ503796A (en)
PL (1) PL191533B1 (en)
PT (1) PT1033132E (en)
RU (1) RU2203665C2 (en)
TR (1) TR200001056T2 (en)
TW (1) TW592728B (en)
WO (1) WO1999020277A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0004132A3 (en) * 1997-10-20 2006-06-28 Dainippon Sumitomo Pharma Co Rapidly soluble drug composition
CN102048734B (en) 2005-05-26 2013-11-20 大日本住友制药株式会社 Pharmaceutical composition
WO2010018866A1 (en) 2008-08-14 2010-02-18 杏林製薬株式会社 Stabilized pharmaceutical composition
CN105769809A (en) * 2014-12-23 2016-07-20 上海星泰医药科技有限公司 Ranirestat with improved bioavailability and preparation method of ranirestat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK607188A (en) * 1987-11-02 1989-06-22 Merck & Co Inc Tablet containing a phthalazineddikesyreforbindelse
TW202450B (en) 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
JPH0518672A (en) * 1991-07-09 1993-01-26 Daido Steel Co Ltd Structure of furnace body in cooling area of heat treatment furnace
DE4141351A1 (en) * 1991-12-14 1993-06-17 Basf Ag Stable powderful vitamin and / or carotinoide preparates and process for their preparation
DE4400464A1 (en) * 1994-01-11 1995-07-13 Bayer Ag endoparasiticides means
DE4440337A1 (en) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug administration than systems with increased saturation solubility and dissolution rate
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
US6297244B1 (en) * 1997-10-20 2001-10-02 Dainippon Pharmaceutical Co., Ltd. Stable drug composition
HU0004132A3 (en) * 1997-10-20 2006-06-28 Dainippon Sumitomo Pharma Co Rapidly soluble drug composition

Also Published As

Publication number Publication date
US20060269599A1 (en) 2006-11-30
HK1030359A1 (en) 2005-08-26
ID23915A (en) 2000-05-25
DE69830333T2 (en) 2006-01-26
CA2306883A1 (en) 1999-04-29
TW592728B (en) 2004-06-21
KR100571614B1 (en) 2006-04-17
CZ20001418A3 (en) 2000-10-11
WO1999020277A1 (en) 1999-04-29
PL191533B1 (en) 2006-06-30
US20020197308A1 (en) 2002-12-26
CA2306883C (en) 2007-11-27
EP1033132A1 (en) 2000-09-06
US7141249B2 (en) 2006-11-28
PT1033132E (en) 2005-09-30
EP1033132B1 (en) 2005-05-25
AT296101T (en) 2005-06-15
DE69830333D1 (en) 2005-06-30
EP1033132A8 (en) 2001-04-04
NZ503796A (en) 2001-11-30
AU740299B2 (en) 2001-11-01
HU0004132A2 (en) 2001-08-28
NO20002049D0 (en) 2000-04-18
CZ299018B6 (en) 2008-04-02
AU9461998A (en) 1999-05-10
PL340045A1 (en) 2001-01-15
TR200001056T2 (en) 2000-09-21
ES2242298T3 (en) 2005-11-01
NO20002049L (en) 2000-06-19
CN1282246A (en) 2001-01-31
KR20010015781A (en) 2001-02-26
BR9814090A (en) 2000-10-03
NO319049B1 (en) 2005-06-06
CN1156277C (en) 2004-07-07
RU2203665C2 (en) 2003-05-10

Similar Documents

Publication Publication Date Title
AU733047C (en) Pharmaceutical composition
AU3553097A (en) Pharmaceutical composition
PL336840A1 (en) Hair-care composition
AP200001785A0 (en) Medicaments
HU9800985A3 (en) Retarde polymere compositions for pharmaceutical compositions
GB9715751D0 (en) Formulations
ZA9703653B (en) Pharmaceutical compositions.
PL194079B1 (en) Highly active phytases-containing composition
HU9601698D0 (en) Pharmaceutical composition
PL194634B1 (en) Omeprazole pharmaceutic preparation
IL135966A (en) 5' - o - alkyl - n - substituted anenosine derivatives, their preparation and pharmaceutical compositiions containing them
IL133293D0 (en) Pharmaceutical compositions comprising cyclodextrins
AU7451198A (en) Solid pharmaceutical preparation
EG24118A (en) Pharmaceutical compositions
IL134961D0 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
EP1017379A4 (en) Therapeutic compositions
EP1030654A4 (en) Omeprazole formulation
EP0938345A4 (en) Aqueous-based pharmaceutical composition
EP0673645A3 (en) Pharmaceutical composition.
ZA9802748B (en) Dermatological composition
HU0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
CY2210B1 (en) Pharmaceutical composition
ZA9509469B (en) Pharmaceutical composition
GB9426252D0 (en) Pharmaceutical composition
IL135536D0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., JP

Free format text: FORMER OWNER(S): DAINIPPON PHARMACEUTICAL CO., LTD., JP

FD9A Lapse of provisional protection due to non-payment of fees